For the second time this year, the US Food and Drug Administration has issued a safety communication to healthcare professionals regarding risk of Type III endoleaks associated with Endologix AFX ...
The US Food and Drug Administration (FDA) is reminding clinicians about the need for "at least yearly, lifelong follow-up" to monitor for type III endoleaks in patients with any type of Endologix AFX ...
Nectero Medical Inc. has secured $19.5 million in a series C financing round, led by Boston Scientific Corp. The company is developing the Endovascular Aortic Stabilization Treatment (EAST) system, a ...
As doxycycline and other tetracyclines are studied for AAA treatment, research needs to remain focused on both slowing aneurysm growth and maintaining the aortic wall integrity. Slowed growth will ...
LOWER MERION – Lankenau Medical Center, part of Main Line Health’s Lankenau Heart Institute, became the first hospital in the state of Pennsylvania to implant the ALTO(R) Abdominal Stent Graft System, ...
Patients with ruptured abdominal aortic aneurysms (AAAs) have substantially lower in-hospital mortality in the United States compared with England, according to an observational study published in the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA issued an alert recommending ...
"Abdominal Aortic Aneurysm Market Insight, Epidemiology And Market Forecast - 2034"The abdominal aortic aneurysm treatment market is experiencing significant expansion, driven by increasing disease ...
Abdominal aortic aneurysm, a weakening and ballooning of the aorta, the largest blood vessel in the body, may result in a life-threatening rupture. In a small, preliminary study examining a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback